-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Red Cat Holdings And 2 Other Penny Stocks Insiders Are Aggressively Buying
Red Cat Holdings And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Dow Jones settled higher by around 175 points on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Erasca
- The Trade: Erasca, Inc. (NASDAQ:ERAS) Director Arthur James Bristol bought a total of 20,000 shares at an average price of $4.14. To acquire these shares, it cost around $82.8 thousand.
- What's Happening: Erasca said first patient was dosed in HERKULES-1 Phase 1b trial evaluating ERAS-007 and ERAS-601 MAPKlamp combination in RAS/MAPK pathway-altered solid tumors.
- What Erasca Does: Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.
Cumberland Pharmaceuticals
- The Trade: Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Director Kenneth Krogulski acquired a total of 3,050 shares at an average price of $2.22. The insider spent around $6.78 thousand to buy those shares.
- What's Happening: Cumberland Pharmaceuticals, last month, posted a profit for its third quarter.
- What Cumberland Pharmaceuticals Does: Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceutical products.
Check This Out: Investor Fear Eases After US Stocks Record Gains
Don't forget to check out our premarket coverage here
Red Cat Holdings
- The Trade: Red Cat Holdings, Inc. (NASDAQ:RCAT) Director, Chairman of the Board, CEO Jeffrey M Thompson acquired a total of 3,300 shares at an average price of $0.79. To acquire these shares, it cost around $2.61 thousand.
- What's Happening: Red Cat recently reported wider-than-expected quarterly loss.
- What Red Cat Holdings Does: Red Cat Holdings Inc provides products, services, and solutions to the drone industry. It offers First Person View (FPV) video goggles to the drone industry, sells FPV drones and equipment, and provides various software and hardware solutions.
The Dow Jones settled higher by around 175 points on Friday. Investors, meanwhile, focused on some notable insider trades.
道琼斯指数周五收盘上涨约175点。与此同时,投资者关注的是一些值得注意的内幕交易。
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
当内部人士买卖股票时,这表明了他们对公司前景的信心或担忧。对细价股感兴趣的投资者和交易员可以在他们的整体投资或交易决策中考虑这一因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是最近几笔值得注意的细价股内幕交易。欲了解更多信息,请查看Benzinga的内幕交易站台。
Erasca
埃拉斯卡
- The Trade: Erasca, Inc. (NASDAQ:ERAS) Director Arthur James Bristol bought a total of 20,000 shares at an average price of $4.14. To acquire these shares, it cost around $82.8 thousand.
- What's Happening: Erasca said first patient was dosed in HERKULES-1 Phase 1b trial evaluating ERAS-007 and ERAS-601 MAPKlamp combination in RAS/MAPK pathway-altered solid tumors.
- What Erasca Does: Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.
- 行业: Erasca,Inc.(纳斯达克:时代)董事亚瑟·詹姆斯·布里斯托尔共买入2万股平均价格为4.14美元。收购这些股份的成本约为82.8万美元。
- 正在发生的事情:Erasca说,第一名患者在Herkules-1 1b期试验中接受了剂量,评估了RAS/MAPK途径改变的实体瘤中ERAS-007和ERAS-601 MAPKLAMP的组合。
- 埃拉斯卡做了什么:Erasca Inc.是一家临床阶段的精确肿瘤学公司,专门致力于发现、开发和商业化RAS/MAPK通路驱动的癌症患者的治疗方法。
Cumberland Pharmaceuticals
坎伯兰制药公司
- The Trade: Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Director Kenneth Krogulski acquired a total of 3,050 shares at an average price of $2.22. The insider spent around $6.78 thousand to buy those shares.
- What's Happening: Cumberland Pharmaceuticals, last month, posted a profit for its third quarter.
- What Cumberland Pharmaceuticals Does: Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription pharmaceutical products.
- 《贸易》: 坎伯兰制药公司。(纳斯达克:CPIX)董事肯尼斯·克罗古尔斯基共购入3,050股平均价格为2.22美元。这位内部人士花了大约67.8万美元购买了这些股票。
- 发生了什么事?:坎伯兰制药公司上个月公布了第三季度的利润。
- 坎伯兰制药公司的业务:坎伯兰制药公司是一家专注于品牌处方药产品的收购、开发和商业化的专业制药公司。
Check This Out: Investor Fear Eases After US Stocks Record Gains
看看这个:美股录得涨幅后投资者担忧缓解
Don't forget to check out our premarket coverage here
别忘了在这里查看我们的售前报道
Red Cat Holdings
红猫控股
- The Trade: Red Cat Holdings, Inc. (NASDAQ:RCAT) Director, Chairman of the Board, CEO Jeffrey M Thompson acquired a total of 3,300 shares at an average price of $0.79. To acquire these shares, it cost around $2.61 thousand.
- What's Happening: Red Cat recently reported wider-than-expected quarterly loss.
- What Red Cat Holdings Does: Red Cat Holdings Inc provides products, services, and solutions to the drone industry. It offers First Person View (FPV) video goggles to the drone industry, sells FPV drones and equipment, and provides various software and hardware solutions.
- 《贸易》: 红猫控股有限公司纳斯达克:RCAT)董事,董事会主席,首席执行官杰弗里·M·汤普森共购入3300股平均价格为0.79美元。收购这些股份的成本约为2.61万美元。
- 发生了什么事?:红猫最近公布的季度亏损超出预期。
- 红猫控股是做什么的:红猫控股公司为无人机行业提供产品、服务和解决方案。它向无人机行业提供第一人称观看(FPV)视频护目镜,销售FPV无人机和设备,并提供各种软硬件解决方案。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧